Clinical Trials
3 trialsNCT01624766 2021-02-25
Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
M.D. Anderson Cancer Center
Phase 1 Completed
NCT03415477 2018-01-30
Deno-ABC
Peking University People's Hospital
Phase 1/2 Completed
NCT00259740 2017-03-15
Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab
Amgen
Phase 2 Completed